The FINANCIAL — Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced on September 20 results of two studies presented at the European Association for the Study of Diabetes (EASD) 46th Annual Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback